Similar articles

• The seroprevalence of anti-HCV in high-risk dialysis patients.

  Bin Selm SA. Bin Selm SA. Saudi J Kidney Dis Transpl. 2011 Jul;22(4):806-7. Saudi J Kidney Dis Transpl. 2011. PMID: 21743237 No abstract available.
• Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.

  Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, Keles H. Yakaryilmaz F, et al. Ren Fail. 2006;28(8):729-35. doi: 10.1080/08860220600925602. Ren Fail. 2006. PMID: 17162434
• Malnutrition inflammation score is associated with coronary artery disease in hepatitis C virus-infected hemodialysis patients.

  Elsurer R, Afsar B, Sezer S, Arat Z, Ozdemir FN, Haberal M. Elsurer R, et al. Eur J Clin Nutr. 2008 Dec;62(12):1449-54. doi: 10.1038/sj.ejcn.1602867. Epub 2007 Aug 1. Eur J Clin Nutr. 2008. PMID: 17671439
• [Anti HCV in hemodialyzed patients: reduction of the prevalence and association with epidemiological variables].

  Padrone M, Corallini O, Cocozzella D, Malca M, Borzi S, Barrio M, Adrover RE, Cuffini AM, Gomez C, Giamona AM, Brawlasky G, Newmann P, Dell Amo M, Fraquelli E, Curciarello JO. Padrone M, et al. Acta Gastroenterol Latinoam. 1999;29(3):91-4. Acta Gastroenterol Latinoam. 1999. PMID: 10533653 Spanish.
• Hepatitis C virus infection in dialysis patients.

  Sułowicz W, Radziszewski A, Chowaniec E. Sułowicz W, et al. Hemodial Int. 2007 Jul;11(3):286-95. doi: 10.1111/j.1542-4758.2007.00181.x. Hemodial Int. 2007. PMID: 17576291 Review.